iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease

By afschroeder • March 13, 2026

Anker SD, Ji L, Kindel T, Coats AJ, Ojji D, Barragán AP, Rossing P, Zieroth S, Ahmad S, Usman S, Appannah G, Bailey AL, Bennis A, Brandao A, Butler J, Davies MJ, Fabryova L, Guo YL, Itoh H, Jadhav UM, Le Roux CW, Pinto FJ, Rosenstock J, Saboo B, Sabbour H, Tiwaskar M, Watson KE, Wei Tham K, Wyss FS, Abhayaratna WP, Abraham WT, Al Mahmeed W, Argirò A, Atherton JJ, Belardo D, Campuzano R, Chatterjee N, Chopra V, Cornier MA, Davies S, de Rueda Panadero C, Dzudie A, Gluckman TJ, Khan MS, Khunti K, Lopatin Y, Ma Z, Ogah OS, Oomman A, Lopez ESP, Li P, Poirier P, Redfern J, Rosano GM, Saraf A, Shaheen S, Verma S, von Haehling S, Zhang Y, Gulati M, Sattar N, Zamorano JL. iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease. J Assoc Physicians India. 2026 Mar;74(3E):e1-e16. doi: 10.59556/japi.74.1445. PMID: 41818109.

Tags: Cardiology/Epi, Publications

Systemic Inflammation and Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease

Sandhu AT, Furst A, Rodriguez F, Kalwani N, Maron D, Nallamshetty S, Din N, Zitko K, Khachatourian K, Skaar JR, Tonnu-Mihara I. Systemic Inflammation and[...]

Breaking Barriers to Transplantation: Desensitization with Daratumumab in Peripartum Cardiomyopathy

Okwuosa I, Kumar A, Choi SM, Kamath M, Vellanki S. Breaking Barriers to Transplantation: Desensitization with Daratumumab in Peripartum Cardiomyopathy. Can J Cardiol. 2026 Apr[...]

Systems Genetics Reveals ITIH5 as a Key Mediator of Adipocyte-Endothelial Crosstalk

Zhou M, Velez LM, Kwan D, Moses L, Johnson CD, Nguyen CM, Mott L, Gamie F, Fouladi M, Bae H, Verlande A, Arneson D, Petrus[...]